Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge

Respirology

Volumn 21, Issue 3, 2016, Pages 410-418

  Tho, Nguyen Van ^a   Park, Hye Yun ^b   Nakano, Yasutaka ^c  

^a University Medical Center   (Viet Nam)

^b Samsung Medical Center   (South Korea)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

asthma; asthma chronic obstructive pulmonary disease overlap syndrome; chronic obstructive pulmonary disease; obstructive airway disease; phenotype

Indexed keywords

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST BENEFIT ANALYSIS; DISABILITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SPIROMETRY; TREATMENT PLANNING; DIFFERENTIAL DIAGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SYNDROME;

ASTHMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SYNDROME;

EID: 84949895524     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12653     Document Type: Review

References (81)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (updated 2015). [Accessed 13 Apr 2015.] Available from URL: http://www.ginasthma.org/
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD (updated 2015). [Accessed 13 Apr 2015.] Available from URL: http://www.goldcopd.org/
3. Jeffery PK,. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2004; 1: 176-183.
4. GINA and GOLD. Diagnosis of diseases of chronic airflow limitation: asthma, COPD and asthma-COPD overlap syndrome (ACOS) (updated 2015). Available from URL: http://www.ginasthma.org/. Accessed: 13 April 2015.
5. Postma DS, Reddel HK, ten Hacken NH, van den Berge M,. Asthma and chronic obstructive pulmonary disease: similarities and differences. Clin. Chest Med. 2014; 35: 143-156.
6. Kim TB, Oh YM, Chang YS, Cho YS, Jang AS, Cho SH, Choi BW, Lee SD, Moon HB,. The reality of an intermediate type between asthma and COPD in practice. Respir. Care 2012; 57: 1248-1253.
7. Miravitlles M, Andreu I, Romero Y, Sitjar S, Altes A, Anton E,. Difficulties in differential diagnosis of COPD and asthma in primary care. Br. J. Gen. Pract. 2012; 62: e68-75.
8. Braman SS,. The chronic obstructive pulmonary disease-asthma overlap syndrome. Allergy Asthma Proc. 2015; 36: 11-18.
9. Bujarski S, Parulekar AD, Sharafkhaneh A, Hanania NA,. The Asthma COPD Overlap Syndrome (ACOS). Curr. Allergy Asthma Rep. 2015; 15: 509.
10. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpelainen M, Kinnula VL, Haahtela T, Laitinen T,. Overlap syndrome of asthma and COPD predicts low quality of life. J. Asthma 2011; 48: 279-285.
11. Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA, Riesco JA, Trigueros JA, Pinera P, Simon A, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch. Bronconeumol. 2014; 50 (Suppl. 1): 1-16.
12. Diaz-Guzman E, Khosravi M, Mannino DM,. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD 2011; 8: 400-407.
13. de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, Casali L, Ferrari M, Nicolini G, Panico MG, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS ONE 2013; 8: e62985.
14. Hersh CP, Jacobson FL, Gill R, Silverman EK,. Computed tomography phenotypes in severe, early-onset chronic obstructive pulmonary disease. COPD 2007; 4: 331-337.
15. Milanese M, Di Marco F, Corsico AG, Rolla G, Sposato B, Chieco-Bianchi F, Costantino MT, Crivellaro MA, Guarnieri G, Scichilone N,. Asthma control in elderly asthmatics. An Italian observational study. Respir. Med. 2014; 108: 1091-1099.
16. Golpe R, Sanjuan Lopez P, Cano Jimenez E, Castro Anon O, Perez de Llano LA,. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch. Bronconeumol. 2014; 50: 318-324.
17. Miravitlles M, Huerta A, Fernandez-Villar JA, Alcazar B, Villa G, Forne C, Cuesta M, Crespo C, Garcia-Rio F,. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual. Life Outcomes 2014; 12: 120.
18. Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K,. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int. J. Chron. Obstruct. Pulmon. Dis. 2012; 7: 283-289.
19. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP,. The clinical features of the overlap between COPD and asthma. Respir. Res. 2011; 12: 127.
20. Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM, Hansell AL, Nowitz MR, McNaughton AA, Soriano JB, et al. Proportional classifications of COPD phenotypes. Thorax 2008; 63: 761-767.
21. Fu JJ, Gibson PG, Simpson JL, McDonald VM,. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration 2014; 87: 63-74.
22. Andersen H, Lampela P, Nevanlinna A, Saynajakangas O, Keistinen T,. High hospital burden in overlap syndrome of asthma and COPD. Clin. Respir. J. 2013; 7: 342-346.
23. Menezes AM, Montes de Oca M, Perez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muino A, Jardim JR, Valdivia G, Talamo C,. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 2014; 145: 297-304.
24. Chung JW, Kong KA, Lee JH, Lee SJ, Ryu YJ, Chang JH,. Characteristics and self-rated health of overlap syndrome. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 795-804.
25. Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS,. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD 2010; 7: 214-228.
26. Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M,. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J. Manag. Care Pharm. 2008; 14: 176-185.
27. Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, Lee JH, Kim Y, Kim K, Kim J, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD 2014; 11: 163-170.
28. Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, Scharf SM,. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008; 134: 14-19.
29. McDonald VM, Simpson JL, Higgins I, Gibson PG,. Multidimensional assessment of older people with asthma and COPD: clinical management and health status. Age. Ageing 2011; 40: 42-49.
30. Hardin M, Cho M, McDonald ML, Beaty T, Ramsdell J, Bhatt S, van Beek EJ, Make BJ, Crapo JD, Silverman EK, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur. Respir. J. 2014; 44: 341-350.
31. Miravitlles M, Soriano JB, Ancochea J, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Garcia-Rio F,. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir. Med. 2013; 107: 1053-1060.
32. Fattahi F, ten Hacken NH, Lofdahl CG, Hylkema MN, Timens W, Postma DS, Vonk JM,. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study. Respir. Res. 2013; 14: 10.
33. Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, Lenburg ME, Spira A, Woodruff PG,. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2015; 191: 758-766.
34. Mauad T, Dolhnikoff M,. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 2008; 14: 31-38.
35. Guerra S, Martinez FD,. Epidemiology of the origins of airflow limitation in asthma. Proc. Am. Thorac. Soc. 2009; 6: 707-711.
36. Postma DS, Kerkhof M, Boezen HM, Koppelman GH,. Asthma and chronic obstructive pulmonary disease: common genes, common environments? Am. J. Respir. Crit. Care Med. 2011; 183: 1588-1594.
37. Shirtcliffe P, Marsh S, Travers J, Weatherall M, Beasley R,. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern. Med. J. 2012; 42: 83-88.
38. Aanerud M, Carsin AE, Sunyer J, Dratva J, Gislason T, Jarvis D, de Marco R, Raherison C, Wjst M, Dharmage SC, et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur. Respir. J. 2015; 45: 635-643.
39. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, Musk AW,. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am. J. Respir. Crit. Care Med. 2005; 171: 109-114.
40. Perret JL, Dharmage SC, Matheson MC, Johns DP, Gurrin LC, Burgess JA, Marrone J, Markos J, Morrison S, Feather I, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am. J. Respir. Crit. Care Med. 2013; 187: 42-48.
41. Tamimi A, Serdarevic D, Hanania NA,. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir. Med. 2012; 106: 319-328.
42. Broekema M, ten Hacken NH, Volbeda F, Lodewijk ME, Hylkema MN, Postma DS, Timens W,. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am. J. Respir. Crit. Care Med. 2009; 180: 1170-1178.
43. Gibson PG, McDonald VM, Marks GB,. Asthma in older adults. Lancet 2010; 376: 803-813.
44. van Schayck CP, Levy ML, Chen JC, Isonaka S, Halbert RJ,. Coordinated diagnostic approach for adult obstructive lung disease in primary care. Prim. Care Respir. J. 2004; 13: 218-221.
45. Barrecheguren M, Esquinas C, Miravitlles M,. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr. Opin. Pulm. Med. 2015; 21: 74-79.
46. Tzortzaki EG, Proklou A, Siafakas NM,. Asthma in the elderly: can we distinguish it from COPD? J. Allergy (Cairo) 2011; 2011: 843543.
47. Zeki AA, Schivo M, Chan A, Albertson TE, Louie S,. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J. Allergy (Cairo) 2011; 2011: 861926.
48. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS,. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58: 322-327.
49. Abramson MJ, Perret JL, Dharmage SC, McDonald VM, McDonald CF,. Distinguishing adult-onset asthma from COPD: a review and a new approach. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 945-962.
50. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE,. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest 2007; 132: 1882-1889.
51. Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, Sigmund R, Seibold W, Moroni-Zentgraf P, Bateman ED,. Tiotropium in asthma poorly controlled with standard combination therapy. N. Engl. J. Med. 2012; 367: 1198-1207.
52. Keith PK, Koch C, Djandji M, Bouchard J, Psaradellis E, Sampalis JS, Schellenberg RR, McIvor RA,. Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can. Respir. J. 2009; 16 (Suppl. A): 17A-31A.
53. Korn D, Van den Brande P, Potvin E, Dramaix M, Herbots E, Peche R,. Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. Curr. Med. Res. Opin. 2009; 25: 489-497.
54. Mirabelli MC, Beavers SF, Chatterjee AB,. Active asthma and the prevalence of physician-diagnosed COPD. Lung 2014; 192: 693-700.
55. Tashkin DP,. Is it asthma, COPD, or something in between, and does it matter? Respir. Care 2012; 57: 1354-1356.
56. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ,. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J. Asthma 2006; 43: 75-80.
57. Burgess JA, Walters EH, Byrnes GB, Wharton C, Jenkins MA, Abramson MJ, Hopper JL, Dharmage SC,. Who remembers whether they had asthma as children? J. Asthma 2006; 43: 727-730.
58. Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, Kesten S,. Bronchodilator responsiveness in patients with COPD. Eur. Respir. J. 2008; 31: 742-750.
59. D'Silva L, Hassan N, Wang HY, Kjarsgaard M, Efthimiadis A, Hargreave FE, Nair P,. Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can. Respir. J. 2011; 18: 144-148.
60. Hancox RJ, Cowan DC, Aldridge RE, Cowan JO, Palmay R, Williamson A, Town GI, Taylor DR,. Asthma phenotypes: consistency of classification using induced sputum. Respirology 2012; 17: 461-466.
61. Vanfleteren LE, Kocks JW, Stone IS, Breyer-Kohansal R, Greulich T, Lacedonia D, Buhl R, Fabbri LM, Pavord ID, Barnes N, et al. Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax 2014; 69: 72-79.
62. Nakawah MO, Hawkins C, Barbandi F,. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J. Am. Board Fam. Med. 2013; 26: 470-477.
63. Louie S, Zeki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, Morrissey BM, Albertson TE,. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev. Clin. Pharmacol. 2013; 6: 197-219.
64. Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, Spears M, McSharry CP, Thomson NC,. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am. J. Respir. Crit. Care Med. 2006; 174: 127-133.
65. Diaz-Guzman E, Mannino DM,. Airway obstructive diseases in older adults: from detection to treatment. J. Allergy Clin. Immunol. 2010; 126: 702-709.
66. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173: 1390-1413.
67. Montuschi P, Malerba M, Santini G, Miravitlles M,. Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping. Drug Discov. Today 2014; 19: 1928-1935.
68. Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, Kessler R,. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2009; 180: 741-750.
69. Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA,. Combination long-acting beta-agonists and inhaled corticosteroids compared with long-acting beta-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA 2014; 312: 1114-1121.
70. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S,. Improvements with tiotropium in COPD patients with concomitant asthma. Respir. Med. 2008; 102: 50-56.
71. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N. Engl. J. Med. 2010; 363: 1715-1726.
72. Miravitlles M, Soler-Cataluna JJ, Calle M, Soriano JB,. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur. Respir. J. 2013; 41: 1252-1256.
73. Leigh R, Pizzichini MM, Morris MM, Maltais F, Hargreave FE, Pizzichini E,. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur. Respir. J. 2006; 27: 964-971.
74. Chanez P, Vignola AM, O'Shaugnessy T, Enander I, Li D, Jeffery PK, Bousquet J,. Corticosteroid reversibility in COPD is related to features of asthma. Am. J. Respir. Crit. Care Med. 1997; 155: 1529-1534.
75. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC,. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60: 282-287.
76. Bellia V, Pistelli R, Catalano F, Antonelli-Incalzi R, Grassi V, Melillo G, Olivieri D, Rengo F,. Quality control of spirometry in the elderly. The SA.R.A. study. SAlute Respiration nell'Anziano = Respiratory Health in the Elderly. Am. J. Respir. Crit. Care Med. 2000; 161: 1094-1100.
77. McDonald VM, Higgins I, Gibson PG,. Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges. Drugs Aging 2013; 30: 1-17.
78. Contoli M, Baraldo S, Marku B, Casolari P, Marwick JA, Turato G, Romagnoli M, Caramori G, Saetta M, Fabbri LM, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J. Allergy Clin. Immunol. 2010; 125: 830-837.
79. Lange P, Celli B, Agusti A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N. Engl. J. Med. 2015; 373: 111-122.
80. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Aldington S, Beasley R,. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur. Respir. J. 2009; 34: 812-818.
81. Pavord ID,. Complex airway disease: an approach to assessment and management. Lancet Respir. Med. 2013; 1: 84-90.